Skip to main content
. 2019 Sep 20;10:1050. doi: 10.3389/fphar.2019.01050

Figure 11.

Figure 11

Comparison of the converged PMFs. (A) FLT3-WT + quizartinib and FLT3-F691L + quizartinib; (B) FLT3-WT + PLX3397 and FLT3-F691L + PLX3397.